Sutro Biopharma, Inc 10-Q for FY2020 Q3
Sutro Biopharma, Inc. (STRO)
10-Q
2020-11-05
For: 2020-09-30
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on November 5, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).
Headline figures
Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $17.82M
- up 45.2% from $12.28M a year earlier
- Net income
- $17.14M
- compared with a net loss of $12.91M a year earlier
- Diluted EPS
- $0.45
- compared with -$0.56 a year earlier